In these early tumour stages, functional studies suggest that CD10 supports cancer progression by inhibiting apoptosis, enhancing cell motility, stimulating invasion, and promoting angiogenesis and dedifferentiation [8,14,16,22,23,33,34]. The gene discussed is MME; the disease is cancer.